1. Home
  2. ABCL vs ATLC Comparison

ABCL vs ATLC Comparison

Compare ABCL & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • ATLC
  • Stock Information
  • Founded
  • ABCL 2012
  • ATLC 1996
  • Country
  • ABCL Canada
  • ATLC United States
  • Employees
  • ABCL N/A
  • ATLC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • ATLC Finance: Consumer Services
  • Sector
  • ABCL Health Care
  • ATLC Finance
  • Exchange
  • ABCL Nasdaq
  • ATLC Nasdaq
  • Market Cap
  • ABCL 772.9M
  • ATLC 813.1M
  • IPO Year
  • ABCL 2020
  • ATLC 1999
  • Fundamental
  • Price
  • ABCL $2.03
  • ATLC $54.87
  • Analyst Decision
  • ABCL Buy
  • ATLC Strong Buy
  • Analyst Count
  • ABCL 3
  • ATLC 5
  • Target Price
  • ABCL $7.50
  • ATLC $60.40
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • ATLC 41.5K
  • Earning Date
  • ABCL 05-08-2025
  • ATLC 05-08-2025
  • Dividend Yield
  • ABCL N/A
  • ATLC N/A
  • EPS Growth
  • ABCL N/A
  • ATLC 23.67
  • EPS
  • ABCL N/A
  • ATLC 5.26
  • Revenue
  • ABCL $23,114,000.00
  • ATLC $424,877,000.00
  • Revenue This Year
  • ABCL N/A
  • ATLC $274.80
  • Revenue Next Year
  • ABCL $36.62
  • ATLC $10.67
  • P/E Ratio
  • ABCL N/A
  • ATLC $10.43
  • Revenue Growth
  • ABCL N/A
  • ATLC 17.71
  • 52 Week Low
  • ABCL $1.89
  • ATLC $23.10
  • 52 Week High
  • ABCL $4.34
  • ATLC $64.70
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 34.87
  • ATLC 54.17
  • Support Level
  • ABCL $1.98
  • ATLC $53.35
  • Resistance Level
  • ABCL $2.64
  • ATLC $56.47
  • Average True Range (ATR)
  • ABCL 0.14
  • ATLC 2.21
  • MACD
  • ABCL -0.06
  • ATLC 0.03
  • Stochastic Oscillator
  • ABCL 7.14
  • ATLC 67.32

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.

Share on Social Networks: